Sunday, January 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – April 14, 2013

by Global Biodefense Staff
April 14, 2013

Biodefense News - Headlines of the WeekClose-contact infection reported as China’s H7N9 tally reaches 49 | Lessons not learned: Insider threats in pathogen research | Senator requests NIH consider pricing issues in drug collaborations | CDC fights plague in Uganda with eye on bioterror threat | The fight to end pandemics | Researchers find salmonella to be more resistant than originally thought | The global distribution and burden of dengue | Making vaccine for new H7N9 virus could be a challenge, experts say | New cutting-edge research will lead to safer medical experiments on humans | Hospital preparedness program and Hurricane Sandy | Why chemotherapy that costs $75K in the U.S. costs $2,500 in India | New bird flu strain seen adapting to mammals, humans | U.S. Supreme Court to decide if companies can patent human genes | CDC preparedness funds take hit in proposed 2014 budget

See what we’re reading this week at Global Biodefense on topics like H7N9 influenza deaths in China, CDC preparedness budget, global dengue assessment and more… 

Close-contact infection reported as China’s H7N9 tally reaches 49 (CIDRAP) 

Lessons not learned: Insider threats in pathogen research (Bulletin Atomic Scientists) 

Senator requests NIH consider pricing issues in drug collaborations (FLC Newslink) 

CDC fights plague in Uganda with eye on bioterror threat (NTI GSN) 

The fight to end pandemics (Forbes)

Researchers find salmonella to be more resistant than originally thought (Virginia Tech) 

The global distribution and burden of dengue (Nature)

Making vaccine for new H7N9 virus could be a challenge, experts say (HuffPost Canada) 

New cutting-edge research will lead to safer medical experiments on humans (USD)

Hospital preparedness program and Hurricane Sandy (PHE.gov) 

Why chemotherapy that costs $75K in the U.S. costs $2,500 in India (The Atlantic) 

New bird flu strain seen adapting to mammals, humans (Univ of Wisconsin-Madison)

U.S. Supreme Court to decide if companies can patent human genes (The Guardian) 

CDC preparedness funds take hit in proposed 2014 budget (CIDRAP)

Related Posts

Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Biodefense Headlines – 15 December 2022
News Scan

Biodefense Headlines – 15 December 2022

December 15, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC